ロード中...
A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and Infliximab Reference Product (Remicade(®)) in Healthy Subjects
OBJECTIVE: SB2, a biosimilar to infliximab reference product (INF), has an identical amino acid sequence and similar physicochemical functional properties to its reference product. The primary objective of this study is to demonstrate pharmacokinetic (PK) bioequivalence between SB2 and EU-sourced IN...
保存先:
| 出版年: | BioDrugs |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4684585/ https://ncbi.nlm.nih.gov/pubmed/26577771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-015-0150-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|